AbbVie
ABBV
#27
Rank
โ‚ฌ344.62 B
Marketcap
195,22ย โ‚ฌ
Share price
-0.37%
Change (1 day)
17.52%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: โ‚ฌ344.62 Billion

As of March 2025 AbbVie has a market cap of โ‚ฌ344.62 Billion. This makes AbbVie the world's 27th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ344.62 B14.01%
2024โ‚ฌ302.29 B22.14%
2023โ‚ฌ247.50 B-7.11%
2022โ‚ฌ266.44 B26.06%
2021โ‚ฌ211.36 B37.43%
2020โ‚ฌ153.79 B31.58%
2019โ‚ฌ116.88 B-1.92%
2018โ‚ฌ119.17 B-7.38%
2017โ‚ฌ128.67 B33%
2016โ‚ฌ96.74 B10.92%
2015โ‚ฌ87.22 B1.86%
2014โ‚ฌ85.62 B41.06%
2013โ‚ฌ60.70 B48.77%
2012โ‚ฌ40.80 B

End of Day market cap according to different sources

On Mar 6th, 2025 the market cap of AbbVie was reported to be:

โ‚ฌ344.62 Billion
by Yahoo Finance info icon info icon
โ‚ฌ344.62 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ344.62 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ137.75 B-60.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ113.12 B-67.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ759.39 B 120.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ158.15 B-54.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ133.86 B-61.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.98 B-94.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ74.20 B-78.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ222.48 B-35.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ10.40 B-96.98%๐Ÿ‡บ๐Ÿ‡ธ USA